enanta pharmaceuticals inc
(ENTA:Consolidated Issue Listed on NASDAQ Global Select )
Robert C. Moellering Jr., M.D.
Clinical Advisor, Enanta Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 88 board members in 10 different organizations across 16 different industries.|
See Board Relationships
Dr. Robert C. Moellering, Jr., M.D. is a Clinical Advisor of Enanta Pharmaceuticals, Inc. Dr. Moellering serves as an Editor-in-Chief of Antimicrobial Agents and Chemotherapy and serves as Editor of both Infectious Disease Clinics of North America and European Journal of Clinical Microbiology and Infectious Diseases. He was the President and Chief Executive Officer of Harvard Medical Faculty Physicians of Beth Israel Deaconess Medical Center, the faculty multispecialty ...
500 Arsenal StreetPhone: 617-607-0800
Watertown, Massachusetts 02472
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Medical School
American College of Physicians
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|